| Dr Chad Edward Froebel, DDS | |
|
362 S Main St, Albion, NY 14411-1603 | |
| (585) 589-0000 | |
| Not Available |
| Full Name | Dr Chad Edward Froebel |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 362 S Main St, Albion, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306283015 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 057265 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chad Edward Froebel, DDS 362 S Main St, Albion, NY 14411-1603 Ph: (585) 589-0000 | Dr Chad Edward Froebel, DDS 362 S Main St, Albion, NY 14411-1603 Ph: (585) 589-0000 |
News Archive
Today the U.S. Food and Drug Administration proposed the Innovation Pathway, a priority review program for new, breakthrough medical devices and announced the first submission: a brain-controlled, upper-extremity prosthetic that will serve as a pilot for the program. The FDA also announced plans to seek further public comment before the Pathway can be used more broadly.
Work is causing stress for more Seattleites this year according to the American Psychological Association's (APA) Stress in America survey, while the number reporting money or the economy as significant stressors has dropped since last year. More than 50 percent of city residents remain stressed by one or more of these three sources, a cause of concern for psychologists who worry about the effects of long-term stress and how it can contribute to chronic health disorders.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
According to the National Institutes of Health, respiratory viruses are the most frequent cause of disease and death in humans, a fact highlighted by the COVID-19 pandemic. Despite the potential to cause severe disease, over 70% of viral infections remain asymptomatic.
Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical "signature" in blood-forming stem cells that predicts whether patients with acute myeloid leukemia (AML) will respond to chemotherapy.
› Verified 6 days ago
Dr. Donald Warren Bishop Jr., DDS Dentist Medicare: Medicare Enrolled Practice Location: 245 South Main St, Suite 1, Albion, NY 14411 Phone: 585-589-5262 Fax: 585-589-1289 | |
Dr. Jeremy Brandwein, DDS Dentist Medicare: Medicare Enrolled Practice Location: 243 S Main St Ste 121, Albion, NY 14411 Phone: 585-589-9044 | |
Dr. Albert J. Monacelli, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 362 S Main St, Albion, NY 14411 Phone: 585-589-7025 Fax: 585-589-0398 | |
Mark Richard Rumble, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 243 South Main Street, Suite 121, Albion, NY 14411 Phone: 585-589-9044 Fax: 585-589-1265 | |
Dr. Karl V Heuer, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 313 S Main St, Albion, NY 14411 Phone: 585-589-4325 | |
Solomia Zhownirovych, Dentist Medicare: Not Enrolled in Medicare Practice Location: 362 S Main St, Albion, NY 14411 Phone: 585-589-0000 |